Literature DB >> 4418356

Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.

S Lindgren, P Collste, B Norlander, F Sjöqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4418356     DOI： 10.1007/BF00558211

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  A colorimetric micromethod for the estimation of antipyrine in plasma or serum.

Authors:  D MENDELSOHN; N W LEVIN
Journal:  S Afr J Med Sci       Date:  1960-04

2.  The use of antipyrine in the measurement of total body water in man.

Authors:  R SOBERMAN; B B BRODIE
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

3.  The estimation of antipyrine in biological materials.

Authors:  B B BRODIE; J AXELROD
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

4.  Individual differences in the plasma half-lives of lipid soluble drugs in man.

Authors:  D S Davies; S S Thorgeirsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

5.  Genetic control of drug levels in man: antipyrine.

Authors:  E S Vesell; J G Page
Journal:  Science       Date:  1968-07-05       Impact factor: 47.728

6.  Metabolism of drugs. LIX. A new metabolite of antipyrine.

Authors:  H Yoshimura; H Shimeno; H Tsukamoto
Journal:  Biochem Pharmacol       Date:  1968-08       Impact factor: 5.858

7.  Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides.

Authors:  B Kolmodin; D L Azarnoff; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

8.  Interindividual differences in drug oxidation: clinical importance.

Authors:  F Sjöqvist; C von Bahr
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

9.  Norphenazone, a new metabolite of phenazone in human urine.

Authors:  J D Baty; D A Evans
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

10.  Genetic control of phenylbutazone metabolism in man.

Authors:  J A Whittaker; D A Evans
Journal:  Br Med J       Date:  1970-11-07
View more
  22 in total

1.  Assessment of antipyrine kinetics by measurement in saliva.

Authors:  H S Fraser; J C Mucklow; S Murray; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

2.  Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.

Authors:  C J van Boxtel; J T Wilson; S Lindgren; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

3.  Effect of vitamin C supplement on antipyrine disposition in man.

Authors:  J B Houston
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

4.  Flupirtine maleate and antipyrine half-life.

Authors:  A Hedges; S J Warrington; P Turner; G Niebch
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Pharmacokinetics of antipyrine in epileptic patients.

Authors:  E M Rimmer; P A Routledge; L M Tsanaclis; A Richens
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

Review 6.  Individual differences in the disposition of drugs metabolised in the body.

Authors:  G Alvan
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

7.  Disappearance of phenazone from plasma in patients with obstructive jaundice.

Authors:  J Elfström; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

Review 8.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

9.  Induction of drug metabolizing enzymes by sulfinpyrazone.

Authors:  E Walter; C Staiger; J de Vries; R Zimmermann; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 10.  Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors:  M Døssing
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.